OTCMKTS:IOBCF - Ion Beam Applications Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$17.96
▲ +0.155 (0.87%)
1 month | 3 months | 12 months
Get New Ion Beam Applications Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IOBCF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IOBCF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Ion Beam Applications in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $17.96.
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Ion Beam Applications. This rating has held steady since January 2021, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/15/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/14/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
6/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
9/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/8/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/21/2020Jefferies Financial GroupDowngradeHold ➝ Underperform
i
(Data available from 3/8/2016 forward)
Ion Beam Applications logo
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. It offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or single photon emission computed tomography radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides measurement and quality assurance instruments for radiotherapy and medical imaging to enable healthcare professionals to verify that equipment administers the planned dose to the targeted area. The company has a strategic alliance with RaySearch Laboratories AB for the advancement of adaptive proton therapy. Ion Beam Applications SA was founded in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Read More

Today's Range

Now: $17.96
$17.81
$17.96

50 Day Range

MA: $17.73
$17.21
$18.93

52 Week Range

Now: $17.96
$6.34
$18.97

Volume

812 shs

Average Volume

338 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Ion Beam Applications?

The following Wall Street sell-side analysts have issued research reports on Ion Beam Applications in the last twelve months:
View the latest analyst ratings for IOBCF.

What is the current price target for Ion Beam Applications?

0 Wall Street analysts have set twelve-month price targets for Ion Beam Applications in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Ion Beam Applications in the next year.
View the latest price targets for IOBCF.

What is the current consensus analyst rating for Ion Beam Applications?

Ion Beam Applications currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for IOBCF.

What other companies compete with Ion Beam Applications?

How do I contact Ion Beam Applications' investor relations team?

The company's listed phone number is 32 1 047 58 11. The official website for Ion Beam Applications is www.iba-worldwide.com.